Drug safety must continue to evolve to meet heightened patient expectations and the fluctuating regulatory climate. It is becoming critical to exploit opportunities offered by emerging technologies, big data and personalised healthcare. To succeed in this new environment, we need to assess the regulatory updates; we need to examine how to implement regulations strategically and operationally in addition to discussing ways to ensure transparency in drug safety. Managing multiple stakeholders successfully is key – integrating patients, physicians, drug manufacturers, regulators and consumers together will enable industry and partners to devise effective drug safety strategies and decisions going forward.
The 10th World Drug Safety Congress Europe 2016 will bring together industry pioneers to explore global challenges in drug safety. This is your opportunity to engage and sit alongside key opinion leaders who are bucking industry trends in pharmacovigilance.